drugset / Trial / NCT02529202
Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
NaSingle-groupOpen-labelTreatment
Summary
The goal of this proposal is to profile the pharmacokinetics of dexmedetomidine in newborns ≥36 weeks post-menstrual age during therapeutic hypothermia for hypoxic-ischemic encephalopathy.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-11
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | — |